糖尿病肢体缺血性病变的干细胞治疗
摘要
随着人们生活方式的改变,糖尿病发病率呈逐年上升趋势。而在导致糖尿病病人致死率和致残率增高的诸多因素中,由高血糖引发的各种糖尿病并发症是主要原因,同时也是决定糖尿病患者预后的重要因素。
出处
《微循环学杂志》
2011年第1期70-72,共3页
Chinese Journal of Microcirculation
参考文献33
-
1The diabetes control and complication trial research group the effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus.N Engl J Med,1993,32(9):977-986.
-
2UK prospective diabetes study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33).Lancet,1998,35(2):837-853.
-
3Mathew V,Gersh BJ,Williams BA,et al.Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era:a report from the prevention of restenosis with tranilast and its outcomes (PRESTO) trial.Circulation,2004,10(9):476-480.
-
4Rivard A,Silver M,Chen D,et al.Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.Am J Pathol,1999,15(4):355-363.
-
5Rumpold H,Wolf D,Koeck R.Endothelial progenitor cells:a source for therapeutic vasculogenesis J Cell Mol Med,2004,8(1):509-518.
-
6Asahara T,Murohara T,Sullivan A,et al.Isolation of putative progenitor endothelial cells for angiogenesis.Science,1997,27(5):964-967.
-
7Urbich C,Dimmeler S.Endothelial progenitor cells:characterization and role in vascular biology.Circ Res,2004,9(5):343-353.
-
8Kalka C,Masuda H,Takahashi T,et al.Transplantation of ex vivo expanded endothelial progenitor cells for therapeuticneovascularization.Proc Natl Acad Sci U S A,2000,9(7):3 422-3 427.
-
9Majka SM,Jackson KA,Kienstra KA,et al.Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration.J Clin Invest,2003,11(1):71-79.
-
10Garlanda C,Dejana E.Heterogeneity of endothelial cells:specific markers.Arterioscler Thromb Vasc Biol,1997,1(7):1 193-1 202.
二级参考文献3
-
1赵志刚,张春玲,张会峰,雷平冲,马书平,汪艳芳,苏永,袁慧娟.自体干细胞移植治疗糖尿病足的临床研究[J].中原医刊,2006,33(10):3-6. 被引量：19
-
2GU Yong-quan ZHANG Jian GUO Lian-rui QI Li-xing ZHANG Shu-wen XU Juan LI Jian-xin LUO Tao JI Bing-xin LI Xue-feng YU Heng-xi CUI Shi-jun WANG Zhong-gao.Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia[J].Chinese Medical Journal,2008(11):963-967. 被引量：22
-
3潘长玉,高妍,袁申元,李光伟,王姮,陆菊明,李俊来,杨国庆,张俊清,陈铭,朱良湘,刘效慈,肖平,张学文,肖新华,李文慧,姜育新.2型糖尿病下肢血管病变发生率及相关因素调查[J].中国糖尿病杂志,2001,9(6):323-326. 被引量：510
共引文献2
-
1谢丽娟,陈卓,崔娜,尹健,杨松柏.血管内皮功能和颈动脉内膜中膜厚度变化在糖尿病肢动脉闭塞症中的表达意义[J].现代生物医学进展,2014,14(25):4865-4868. 被引量：2
-
2韩雪立,刘东,张秀娟,周盈.自体骨髓干细胞移植联合经皮腔内血管成形术治疗糖尿病足的效果评价[J].吉林大学学报（医学版）,2016,42(1):125-129. 被引量：7
-
1高建秋,王海霞,王爱华.血管紧张素转换酶抑制剂的临床应用[J].中国医刊,2012,47(8):25-27. 被引量：6
-
2郭清保,周翔宇,施森,何延政.糖尿病肢体缺血后血管新生能力受损机制探讨[J].国际外科学杂志,2010,37(10):705-709.
-
3陈霞.川芎嗪注射液联合前列腺素E1治疗糖尿病下肢动脉闭塞症的临床观察[J].现代中西医结合杂志,2006,15(24):3361-3361. 被引量：1
-
4王黎君,何泽.前列地尔治疗糖尿病下肢动脉闭塞症的临床观察[J].中国老年学杂志,2005,25(12):1555-1556. 被引量：3
-
5孙连庆,杨雁.糖尿病肢体动脉闭塞症与血栓素B_2、6-keto-PGF_(lα)的关系[J].实用糖尿病杂志,2006,2(2):26-28. 被引量：1
-
6俞维英,李明祥,王翔.川芎嗪与疏血通联合治疗糖尿病下肢动脉病变80例临床观察[J].中国中医药科技,2010,17(3):249-249. 被引量：2
-
7肖美群,刘伟信,张勇.植物雌激素治疗糖尿病肢体缺血性周围神经病变的试验研究[J].中外医疗,2015,34(9):11-12.
-
8吴庆华.糖尿病肢体动脉闭塞症手术疗法[J].中国中西医结合外科杂志,2003,9(6):420-422. 被引量：2
-
9邓江华.糖尿病肢体动脉硬化的中西医结合治疗临床效果探讨[J].医学信息（下旬刊）,2011,24(6):81-81.
-
10刘晓阳,杜玉名,王福涛.疏血通治疗糖尿病下肢动脉病变临床的观察[J].吉林医学,2003,24(3):267-267.
